MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0085400
Medicure Formulations Private Limited
Medicure Formulations Private Limited - trading in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.69 Cr
▲ 22% YoY
Net profit · FY 2025
₹9.6 Lakh
Net margin 3.6%
EBITDA · FY 2025
₹15.92 Lakh
EBITDA margin 5.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹50 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
About Medicure Formulations Private Limited
Data last updated:
Medicure Formulations Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 03 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2020PTC335486. Its GSTIN is 27AANCM2145E1ZJ (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jayprakash Yadav and Pooja Jayprakash Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No 8 Shanti Garden Chs Shrushti Opposite Surya Shopping Centre Mira Road, Thane, Maharashtra, India – 401107.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.69 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹9.6 Lakh (net margin 3.6%) and EBITDA of ₹15.92 Lakh (EBITDA margin 5.9%). Revenue has grown at a compounded annual rate (CAGR) of 46% over three years.
As per MCA filings, the company has open charges of ₹50 Lakh on record.
Medicure Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0085400).
Company Details of Medicure Formulations Private Limited
CIN U51909MH2020PTC335486
Registration Number 335486
Incorporation Date 03 January 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0085400
Recognitions & Rankings of Medicure Formulations
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No 8 Shanti Garden Chs Shrushti Opposite Surya Shopping Centre Mira Road, Thane, Maharashtra, India – 401107
- IndustryTrading, Specialty, Wholesale
Comprehensive company report
Medicure Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity
The main business activity of Medicure Formulations is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Medicure Formulations Private Limited
FY 2025 filings availableMedicure Formulations Private Limited reported revenue of ₹2.69 Cr (up 22% YoY) for FY 2025.
Revenue · FY 2025
₹2.69 Cr ▲ 22%
Net profit · FY 2025
₹9.6 Lakh margin 3.6%
EBITDA · FY 2025
₹15.92 Lakh margin 5.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 46%
EBITDA CAGR growth
1 year
▼ 31%
3 years · compounded
▲ 42%
Revenue has grown at a compounded annual rate (CAGR) of 46% over three years, including 22% growth in the latest year. EBITDA fell 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹15.92 Lakh | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹9.6 Lakh | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 5.9% | |
| Net Profit Margin | 3.6% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2020-21 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medicure Formulations are in the company report.
: available in the company report
Board of Directors of Medicure Formulations Private Limited
Medicure Formulations has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jayprakash Yadav | Director | 03 Jan 2020 | 6 Years 9 Months | Current |
| Pooja Jayprakash Yadav | Director | 03 Jan 2020 | 6 Years 9 Months | Current |
Peer Comparison
Medicure Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution), with the same principal business activity (wholesale trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Andromeda Pharmaceuticals Private Limited | ₹2.69 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Indore, Madhya Pradesh, India |
| Medicure Formulations Private Limited this company | ₹2.69 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Thane, Maharashtra, India |
| Zaria Pharmaceuticals Private Limited | ₹2.69 Cr (FY 2025) | •••• | •••• | -20.0% | •••• | Thane, Maharashtra, India |
| Conset Pharma Private Limited | ₹2.69 Cr (FY 2024) | •••• | •••• | -11.0% | •••• | Indore, Madhya Pradesh, India |
| Rynel Clifton Pharma Private Limited | ₹2.68 Cr (FY 2024) | •••• | •••• | -12.0% | •••• | Hisar, Haryana, India |
| Med-Esales Life Sciences Private Limited | ₹2.68 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Agra, Uttar Pradesh, India |
Peers are the companies nearest to Medicure Formulations by revenue, above and below it, in the Pharma industry (Formulations, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Open charges
₹50 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 2024 | Others | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Medicure Formulations.
: available in the company report
Recent Activity
Medicure Formulations Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Jayprakash Yadav was appointed as Director on 03 Jan 2020.
AGM
Medicure Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medicure Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 101036324 was registered on 30 Dec 2024.
Appointed
Jayprakash Yadav was appointed as Director.
Appointed
Pooja Jayprakash Yadav was appointed as Director.
Incorporation
03 Jan 2020
Medicure Formulations Private Limited was registered on 03 Jan 2020 with Roc Mumbai Ii & aged 6 years 9 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Medicure Formulations has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AANCM2145E1ZJ | Maharashtra | Active | 19 Mar 2020 |
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Medicure Formulations is an active private limited company based in Thane, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 03 January 2020 (6+ years old) and is registered under CIN U51909MH2020PTC335486.
Medicure Formulations has 2 current directors:
- Jayprakash Yadav - Director
- Pooja Jayprakash Yadav - Director
The latest financial statements of Medicure Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Medicure Formulations is 27AANCM2145E1ZJ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Medicure Formulations is U51909MH2020PTC335486. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medicure Formulations was incorporated on 03 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Medicure Formulations by revenue are Andromeda Pharmaceuticals Private Limited, Zaria Pharmaceuticals Private Limited, Conset Pharma Private Limited, Rynel Clifton Pharma Private Limited, Med-Esales Life Sciences Private Limited, all in the Pharma industry (Formulations, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Jayprakash Yadav was appointed as Director on 03 Jan 2020. Pooja Jayprakash Yadav was appointed as Director on 03 Jan 2020.
Yes, Medicure Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0085400).
The registered office of Medicure Formulations is at Shop No 8 Shanti Garden Chs Shrushti Opposite Surya Shopping Centre Mira Road, Thane, Maharashtra, India – 401107.
Medicure Formulations operates in the trading industry, in the specialty segment.